209 related articles for article (PubMed ID: 15813833)
21. Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms.
Oridate N; Takeda H; Yamamoto J; Asaka M; Mesuda Y; Nishizawa N; Mori M; Furuta Y; Fukuda S
Laryngoscope; 2006 Apr; 116(4):547-53. PubMed ID: 16585857
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
23. Gastro-oesophageal reflux and Helicobacter pylori.
Pace F; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S289-93. PubMed ID: 10077757
[TBL] [Abstract][Full Text] [Related]
24. The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection.
Bercík P; Verdú EF; Armstrong D; Idström JP; Cederberg C; Markert M; Crabtree JE; Stolte M; Blum AL
Am J Gastroenterol; 2000 Apr; 95(4):947-55. PubMed ID: 10763943
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
[TBL] [Abstract][Full Text] [Related]
26. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
Lundell L
Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
[TBL] [Abstract][Full Text] [Related]
27. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.
Schenk BE; Kuipers EJ; Nelis GF; Bloemena E; Thijs JC; Snel P; Luckers AE; Klinkenberg-Knol EC; Festen HP; Viergever PP; Lindeman J; Meuwissen SG
Gut; 2000 May; 46(5):615-21. PubMed ID: 10764703
[TBL] [Abstract][Full Text] [Related]
28. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
Hage E; Hendel L; Gustafsen J; Hendel J
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
[TBL] [Abstract][Full Text] [Related]
29. [Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].
Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Ned Tijdschr Geneeskd; 1998 Apr; 142(16):883-5. PubMed ID: 9623181
[TBL] [Abstract][Full Text] [Related]
30. Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
Kubben FJ; Sier CF; Schram MT; Witte AM; Veenendaal RA; van Duijn W; Verheijen JH; Hanemaaijer R; Lamers CB; Verspaget HW
Helicobacter; 2007 Oct; 12(5):498-504. PubMed ID: 17760717
[TBL] [Abstract][Full Text] [Related]
31. Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.
Diebold MD; Richardson S; Duchateau A; Bigard MA; Colin R; Cortot A; Fauchère JL; Zeitoun P
Dig Dis Sci; 1998 Aug; 43(8):1629-35. PubMed ID: 9724142
[TBL] [Abstract][Full Text] [Related]
32. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
Fukuchi T; Ashida K; Yamashita H; Kiyota N; Tsukamoto R; Takahashi H; Ito D; Nagamatsu R
J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
[TBL] [Abstract][Full Text] [Related]
33. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
34. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
[TBL] [Abstract][Full Text] [Related]
35. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
Katsinelos P; Tziomalos K; Chatzimavroudis G; Vasiliadis T; Katsinelos T; Pilpilidis I; Triantafillidis I; Paroutoglou G; Papaziogas B
Med Princ Pract; 2007; 16(2):119-23. PubMed ID: 17303947
[TBL] [Abstract][Full Text] [Related]
36. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
37. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
Tefera S; Hatlebakk JG; Berstad A
Am J Gastroenterol; 2001 Apr; 96(4):969-74. PubMed ID: 11316213
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis.
Mihara T; Adachi K; Komazawa Y; Yoshida M; Araki A; Maruyama R; Furuta K; Ishihara S; Amano Y; Kinoshita Y
J Gastroenterol Hepatol; 2005 May; 20(5):682-7. PubMed ID: 15853979
[TBL] [Abstract][Full Text] [Related]
39. Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
Madisch A; Miehlke S; Neuber F; Morgner A; Kuhlisch E; Rappel S; Lehn N; Bayerdörffer E; Seitz G; Stolte M
Aliment Pharmacol Ther; 2006 Feb; 23(4):473-9. PubMed ID: 16441467
[TBL] [Abstract][Full Text] [Related]
40. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
